Moderate to Severe Alzheimer's Disease
3 clinical trials · Condition
◉ Watch Moderate to Severe Alzheimer's Disease
| Record | Firm | Date |
|---|---|---|
| BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease (NCT04229927) | Hyundai Pharmaceutical Co., LTD. | 2020-02-27 |
| Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (NCT00866060) | King's College London | 2008-02-01 |
Track Moderate to Severe Alzheimer's Disease automatically
Every clearance here is in the API, with alerts when new ones post.